So glad you enjoyed it!

EACR-Mark Foundation for Cancer Research Postdoctoral Fellowships are awarded for a period of three years and support excellent postdoctoral researchers in laboratories throughout Europe. Is that you? 👀 Apply by 19 August: eacr.org/eacr-fellows...

Julie Marie Mazet delivers the EACR - @themarkfdn.bsky.social Postdoctoral Fellowship Award Lecture on unlocking CD8+ T cell anti-tumour activity in brain metastasis at #EACR2026

Very happy to present my work at #EACR2026, made possible through the support of EACR- @themarkfdn.bsky.social Postdoctoral Fellowship 😊 #womeninSTEM

It was a pleasure to present my research at #EACR2026, supported by @helloeacr.bsky.social @themarkfdn.bsky.social postdoctoral fellowship. Thank you to all organizers & participants!

Clinical trial results don’t usually get standing ovations—but Brian Wolpin and his team truly deserved their reception at #ASCO26. Seeing Phase 3 data on the impact of daraxonrasib in patients with advanced pancreatic cancer sent chills through the entire room. 🧵 www.theguardian.com/society/2026...

Great feature on Drug Discovery Award winner @corsello.bsky.social by @stanforddeptmed.bsky.social! Corsello and his collaborator, Nathanael Gray, are developing novel molecular glue degraders for #pancreaticcancer. medicine.stanford.edu/news/stories...

Exciting new work from Professor Chris Garcia, co-investigator on MATCHMAKERS 👏 Team MATCHMAKERS is funded through Cancer Grand Challenges by @cancerresearchuk.org, the National Cancer Institute and @themarkfdn.bsky.social

When do cells shift from benign to malignant? In @cellcellpress.bsky.social, Endeavor Awardees Scott Lowe, @danapeer.bsky.social, and Paul Romesser use spatial mapping to identify a "progenitor" state that could be targeted for early interception of pancreatic cancer. www.cell.com/cell/fulltex...

1 in 100 women in the US will be diagnosed with ovarian cancer in their lifetime. For more than half, that diagnosis will come once the disease has already spread, when treatment options are limited. Two of our recent grants aim to change that reality. #WorldOvarianCancerDay.

📢 Funding opportunity: $500,000 grants for aging & cancer research!📢 With the Waxman Institute, @theaacr.bsky.social @bloodcancerunited.bsky.social, @bloodcanceruk.bsky.social & the Mike and Sofia Segal Foundation, we are seeking proposals that examine the fundamental role of aging in cancer.

How does lung cancer actually spread? In @Nature, ASPIRE Awardee @charlesswanton.bsky.social sequenced 501 tumor samples to trace how cancer advances from diagnosis to death. One key finding: >50% of metastases were seeded by other metastases.  www.nature.com/articles/s41...

Are you in years 3-8 of an independent faculty position? The Emerging Leader Award was built to give you the research runway you need. The award now offers $1M over 4 years and is open to investigators worldwide!🌎 Apply by April 30: themarkfoundation.org/emerging-lea... #ResearchFunding

We're proud that over 60 members of the Mark Foundation community are presenting or chairing sessions at #AACR26! Headed to San Diego? We've made a list of their talks to help you plan your weekend: themarkfoundation.org/blog/mark-fo...

Do you know an early-career scientist pushing the boundaries of cancer research?🧬 Our Emerging Leader Award offers $1M in #researchfunding to investigators worldwide. Tag a colleague or share this post to help us spread the word! LOI deadline is April 30.

Did you catch our news during #MarkSymposium? We’re accepting applications for our 2026 Emerging Leader Awards, now offering $1 million over 4 years & open to investigators worldwide! Submit your LOI by April 30: themarkfoundation.org/emerging-lea... #ResearchFunding

Immune surveillance can be a double-edged sword. ⚔️ In @nature.com, Endeavor Awardee Tobias Janowitz shows that the same B cell response targeting NMDAR-expressing breast cancer tumors can mature into antibodies that trigger autoimmune disease. www.nature.com/articles/s41...

Our final talks at #MarkSymposium 2026 focused on cancer immunology, with deep dives into autoantibodies by @aaronmring.bsky.social and T cell exhaustion by @ejohnwherry.bsky.social.

Can diet be a drug? 🥦 Jennifer McQuade and Semir Beyaz explored the link between nutrition and cancer therapy response, with insights on how lipids, fiber, & the microbiome shape immune responses. #MarkSymposium

📢We have exciting news to share on Day 2 of #MarkSymposium: Applications for this year’s Emerging Leader Awards are now open! These early career awards are now $1 million, and researchers anywhere in the world are eligible. Learn more: themarkfoundation.org/2026/03/the-...

We're back with Day 2 of #MarkSymposium! Our first session, on novel cancer therapies, featured a powerhouse lineup including William Sellers, @amanglik.bsky.social, and @juliensage.bsky.social. The future of targeted treatment is bright. ⚡️ #CancerTherapy

Last night, we honored the legendary Samuel Waxman, MD, for his remarkable scientific career & leadership as the founder of the Samuel Waxman Cancer Research Foundation. Cheers to the future of the Waxman Institute for Aging & Cancer, now officially a branch of The Mark Foundation! #MarkSymposium

Our second session of the day focused on Cancer Across the Lifespan, with excellent talks on the intersection of aging & cancer by @naxerova.bsky.social, Scott Lowe, and Kornelia Polyak. 🧬 #MarkSymposium

🏆This year, we’re thrilled to have Nobel Laureate William Kaelin Jr., MD, delivering our keynote address. Incredible to get insights on the frontiers of research from a true leader in the field! #MarkSymposium

And now, the 2026 #MarkSymposium has officially begun! Our first session is a deep dive into brain tumors.🧠 Grateful to hear from Peter Sorger, Mario Suva, & Dimitrios Mathios on how spatial analysis and liquid biopsies are changing the game for #glioblastoma detection and treatment. #MarkSymposium

Happening now - our inaugural Emerging Leader Award Summit!🌟 In addition to sharing updates on their work, our ELA awardees are discussing the pressing challenges faced by early-career researchers & how foundations like The Mark Foundation can support them. #MarkSymposium

Last night, current and past Mark Foundation Emerging Leader Award (ELA) winners gathered with this year’s recipients (@jborniger.bsky.social, Christine Chio, @lucas.farnunglab.com, Mariella Filbin & Christopher Johnston) to celebrate eight years of this transformational program. #MarkSymposium

The 2026 Mark Foundation Scientific Symposium officially kicks off tomorrow!🧬 We’re hosting over 200 scientists from around the globe to hear & discuss the latest breakthroughs in cancer research from our grantees. Stay tuned for live updates! #MarkSymposium #CancerResearch

Congratulations to I3H member Nikolaos Sgourakis (University of Pennsylvania & Children’s Hospital of Philadelphia) on new funding from the @themarkfdn.bsky.social and a new coalition of leading nonprofits dedicated to advancing early cancer detection. Learn more: https://bit.ly/3MVytRW

The Mark Foundation is thrilled to announce our 2026 Momentum Fellows! 🚀 We are supporting 9 brilliant investigators—4 new recipients & 5 renewals—tackling everything from immunosuppression to CAR-T cell exhaustion. Meet the future of cancer research: themarkfoundation.org/2026/02/the-...

Huge congratulations to Mark Foundation grantees Catherine Wu & Darrell Irvine for being named to the 2026 @Time 100 Health list! 🏆 🧬Learn how their work is redefining the future of oncology. themarkfoundation.org/blog/56202/ #TIME100 #CancerResearch

📢 In partnership with the Sontag Foundation, @braintumor.org, the Southeastern Brain Tumor Foundation, the Uncle Kory Foundation & Fondation Anne et Claude Berda, we're committing new funding to 5 teams tackling the world’s most aggressive brain tumor. 🧠🧬 themarkfoundation.org/2026/02/the-...

We are proud to join forces with a new coalition of leading organizations including @theaacr.bsky.social, @break-cancer.bsky.social, @lustgarten.org & @themarkfdn.bsky.social! Together we will fund $12mm to 6 teams focused on early detection of some of the most challenging cancers including ovarian.

📢 Announcing the 2026 Early Detection Award recipients! 📢 In partnership with @theaacr.bsky.social, @lustgarten.org, @break-cancer.bsky.social, and @tinaswish.bsky.social, we are committing $12 million to 6 teams developing new diagnostic approaches for the world’s deadliest cancers. 🧬🔬

In an increasingly uncertain funding environment, how can philanthropy effectively support cancer research? In After Treatment, CEO Ryan Schoenfeld tells @grogowl.bsky.social how The Mark Foundation continues to advance game-changing science. www.after-treatment.com/p/where-is-t...

Honored to receive the EACR Rising Star Award 2026. Thanks to @helloeacr.bsky.social, @themarkfdn.bsky.social, and the Pezcoller Foundation for the support. This backs a vision we deeply believe in: time-resolved dynamics are key in cancer–immune interactions. tinyurl.com/45vpm3rr

Congratulations to Daniel Birschenkaum of @dkfz.bsky.social, the 2026 recipient of the @helloeacr.bsky.social-Mark Foundation-Pezcoller Rising Star Award! The award will support his work exploring the dynamic behavior of immune cells in brain tumors. themarkfoundation.org/2026/01/dani...

🚨 New research from the CancerGrand Challenges SPECIFICANCER team (co-funded by The Mark Foundation & @cancerresearchuk.org) highlights NPM1 as a promising target for bowel & liver cancer. Read more in @the-independent.com: www.independent.co.uk/news/health/...

Congratulations to Mark Foundation Scientific Advisory Committee chair and Board member @rosslevinemd.bsky.social !

📢 Announcing The Mark Foundation 2026 Emerging Leader Award winners! 📢 We are committing $3.75 million to 5 visionary early-career scientists poised to lead the next generation of oncology breakthroughs. We can't wait to see their impact! themarkfoundation.org/2026/01/2026...

We're back from the @theaacr.bsky.social Special Conference on Early Onset Cancers! A major highlight was the update from Mark Foundation-Waxman Foundation grantee Ashani Weeraratna on her research into how the aging tumor immune microenvironment influences tumor progression. #AACRearlyonset25

What happens when the scientist becomes the subject? Emerging Leader Award winner Ansuman Satpathy & collaborator Caleb Laureau are challenging conventional wisdom in genetics using findings from Satpathy’s own DNA. themarkfoundation.org/blog/the-sci...

📢 New Impact Report from SPECIFICANCER, the team unravelling one of cancer biology’s hardest puzzles: tissue specificity. A huge thank you to the team and thanks to our co-funders, @themarkfdn.bsky.social and @cancerresearchuk.org for supporting global science. 🔗 lnkd.in/dQC-iHmK

The Mark Foundation scientific community will be well represented at #ASH25! Heading to Orlando? Don't miss these presentations, moderated sessions, and posters from our grantees. themarkfoundation.org/blog/mark-fo...

From bench to bedside! In a Phase 1 trial, a vaccine targeting a neoantigen in fibrolamellar hepatocellular carcinoma (FLC), a rare liver cancer primarily affecting younger people, showed significant clinical benefit when combined with immune checkpoint inhibitors. www.nature.com/articles/s41...

Every day counts in the fight against cancer—and we can’t afford to let reduced federal funding slow progress. Your support this #GivingTuesday helps The Mark Foundation fund ambitious science and bring breakthroughs to the patients who need them. themarkfoundation.org/donate/

Read the newly published impact report from the SPECIFICANCER team that reshaped our understanding of tissue specificity. Thanks to our co-funders, @themarkfdn.bsky.social, for supporting the #CancerGrandChallenges team and global science. 🔗 lnkd.in/eDrQ9guu

What a wonderful few days we've had together in Bergamo at The Rise of Early-Onset Cancers 🎉 Thank you to everyone who attended, our co-organisers @themarkfdn.bsky.social and to the Scientific Programme Committee for all the dedication they put into the great science showcased in the conference!

Members of NexTGen (co-funded by @themarkfdn.bsky.social), Nikolaos Sgourakis & John Maris, contributed to a new Nature paper from David Baker’s lab showing AI-designed antibodies with atomic-level precision A potential game-changer 👉 nature.com/articles/s41586-025-09721-5

It's been a productive 3 days in Bergamo, Italy, at the @helloeacr.bsky.social - Mark Foundation Joint Conference: The Rise of Early-Onset Cancers! Participants have shared new insights into the rise in cancer among young patients & identified paths forward for prevention, detection, & treatment.